High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus

American Journal of Reproductive Immunology

Volumn 66, Issue 2, 2011, Pages 84-89

  Torricelli, Michela ^a   Bellisai, Francesca ^a   Novembri, Romina ^a   Galeazzi, Luna R ^a   Iuliano, Annamaria ^a   Voltolini, Chiara ^a   Spreafico, Adriano ^a   Galeazzi, Mauro ^a   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Activin A; IL 17; SLE pregnancy

Indexed keywords

ACTIVIN A; FOLLISTATIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MATERNAL BLOOD; MATERNAL SERUM; PLACENTA; PREGNANCY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACTIVINS; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-17; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PROSPECTIVE STUDIES;

EID: 79960187365     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.00978.x     Document Type: Article

References (48)

1. Elenkov IJ, Hoffman J, Wilder RL: Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Mol Med Today 1997; 3:379-383.
2. Le Thi Huong D, Wechsler B, Vauthier-Brouzes D, Duhaut P, Costedoat N, Andreu MR, Lefebvre G, Piette JC: The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology 2006; 45:332-338.
3. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF III, Petraglia F: Inflammation and Pregnancy. Reprod Sci 2009; 16:206-215.
4. Petri M: Pregnancy and rheumatic diseases. Rheum Dis Clin North Am 1997; 1:1-208.
5. Wilder RL: Hormones, pregnancy, and autoimmune diseases. Ann N Y Acad Sci 1998; 840:45-50.
6. Doria A, Ghirardello A, Iaccarino L, Zampieri S, Punzi L, Tarricone E, Ruffatti A, Sulli A, Sarzi-Puttini C, Gambari PF, Cutolo M: Pregnancy, cytokines and disease activity in systemic lupus erythematosus. Arthritis Rheum 2004; 51:989-995.
7. Hagiwara E, Gourley MF, Lee S, Klinman DM: Disease severity in patients with systemic lupus erythematosus correlate with an increased ratio of interleukin-10: interferon-γ- secreting cells in the peripheral blood. Arthritis Rheum 1996; 39:379-385.
8. Houssiau FA, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer JP, Renauld JJ: Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995; 4:393-395.
9. Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J et al.: Role of the interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181:839-844.
10. Diehl S, Rincon M: The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 2002; 39:531-536.
11. Al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S: Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic disease. J Clin Immunol 1993; 13:58-67.
12. Studnicka-Benke A, Steiner G, Petera P, Smolen JS: Tumor necrosis factor-α and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996; 35:1067-1074.
13. Dong C: Regulation and pro-inflammatory function of interleukin- 17 family cytokines. Immunol Rev 2008; 226:80-86.
14. Miossec P: IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect 2009; 11:625-630.
15. Nistala K, Wedderburn LR: Th17 and regulatory T cells: rebalancing pro- and anti inflammatory forces in autoimmune arthritis. Rheumatology (Oxford) 2009; 48:602-606.
16. Pene J, Chevalier S, Preisser L, Venereau E, Guilleux MH, Ghannam S et al.: Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008; 180:7423-7430.
17. Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J et al.: Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 2008; 9:166-175.
18. Lin H, Mosman TR, Guilbert L et al.: Synthesis of T helper-2-cytokines at the maternal-fetal interface. J Immunol 1993; 151:4562-4573.
19. Greig PC, Herbert WN, Robinette BL et al.: Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. Am J Obstet Gynecol 1995; 173:1223-1227.
20. Branch DW: Physiologic adaptation of pregnancy. Am J Reprod Immunol 1992; 28:120-122.
21. Peaceman D, Aderka D et al.: Soluble tumor necrosis factor receptors in maternal plasma and second-trimester amniotic fluid. Am J Obstet Gynecol 1995; 173:900-905.
22. Nakashima A, Ito M, Yoneda S, Shiozaki A, Hidaka T, Saito S: Circulating and decidual Th17 cell levels in healthy pregnancy. Am J Reprod Immunol 2010; 63:104-109.
23. Letterio JJ, Roberts AB: Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16:137-161.
24. Petraglia F, Sacerdote P, Cossarizza A et al.: Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-gamma production. J Clin Endocrinol Metab 1991; 72:496-502.
25. Ogawa K, Funaba M, Mathews LS, Mizutani T: Activin A stimulates type IV collagenase (matrix metalloproteinase-2) production in mouse peritoneal macrophages. J Immunol 2000; 165:2997-3003.
26. Funaba M, Ikeda T, Ogawa K, Murakami M, Abe M: Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration. J Leukoc Biol 2003; 73:793-801.
27. Shao L, Frigon NL Jr, Sehy DW et al.: Regulation of production of activin A in human marrow stromal cells and monocytes. Exp Hematol 1992; 20:1235-1242.
28. Hübner G, Werner S: Serum growth factors and proinflammatory cytokines are potent inducers of activin expression in cultured fibroblasts and keratinocytes. Exp Cell Res 1996; 228:106-113.
29. Shao LE, Frigon NL Jr, Yu A, Palyash J, Yu J: Contrasting effects of inflammatory cytokines and glucocorticoids on the production of activin A in human marrow stromal cells and their implications. Cytokine 1998; 10:227-235.
30. Phillips DJ, de Kretser DM, Hedger MP: Activin and related proteins in inflammation: not just interested bystanders. Cytokine Growth Factor Rev 2009; 20:153-164.
31. Phillips DJ, de Kretser DM: Follistatin: a multifunctional regulatory protein. Front Neuroendocrinol 1998; 19:287-322.
32. De Kretser DM, Hedger MP, Phillips DJ: Activin A and follistatin: their role in the acute phase reaction and inflammation. J Endocrinol 1999; 161:195-198.
33. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-1277.
34. Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
35. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M et al; the European Consensus Study Group for Disease Activity in SLE. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992;10:541-547.
36. Doria A, Cutolo M, Ghirardello A, Zampieri S, Vescovi F, Sulli A et al.: Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum 2002; 47:202-209.
37. Zhao XF, Pan HF, Yuan H, Zhang WH, Li XP, Wang GH et al.: Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep 2010; 37:81-85.
38. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T et al.: IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8:967-974.
39. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson Co et al.: Transforming growth factorbeta induces development of the TH17 lineage. Nature 2006; 441:231-234.
40. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B et al.: Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204:1849-1861.
41. Reis FM, D'Antona D, Petraglia F: Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev 2002; 23:230-257.
42. Werner S, Alzheimer C: Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev 2006; 17:157-171.
43. Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME et al.: Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol 2006; 22:234-241.
44. Robak E, Sysa-Jedrzejowska A, Robak T: Cytokines in systemic lupus erythematosus. Przegl Lek 1996; 53:623-626.
45. Wong CK, Ho CY, Li EK, Lam CW: Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000; 9:589-593.
46. Ostensen M, Forger F, Villiger P: Cytokines and pregnancy in rheumatic disease. Ann N Y Acad Sci 2006; 1069:353-363.
47. Ellis J, Wennerholm UB, Bengtsson A, Lilja H, Pettersson A, Sultan B et al.: Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 2001; 80:602-608.
48. Bahar A, Ghalib H, Moosa RA, Zaki ZM, Thomas C, Nabri OA: Maternal serum interleukin-6, interleukin-8, tumor necrosis factor-a and interferon- g in preterm labor. Acta Obstet Gynecol Scand 2003; 82:543-549.